𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dexamethasone therapy in chronic lung disease

✍ Scribed by Smeeta Sardesai; Manuel Durand

Book ID
112903441
Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
310 KB
Volume
63
Category
Article
ISSN
0019-5456

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevention of chronic lung disease in pr
Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy
✍ Yuh J. Lin; Tsu F. Yeh; Wu S. Hsieh; Yun C. Chi; Hong C. Lin; Chyi H. Lin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 48 KB πŸ‘ 2 views

Recent studies suggest that early dexamethasone therapy may lessen the pulmonary inflammation in preterm infants with respiratory distress syndrome (RDS). To investigate whether early (<12 hr) postnatal dexamethasone therapy would reduce the incidence of chronic lung disease (CLD), a randomized, dou

Meta-analysis of dexamethasone therapy s
Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants
✍ Jose M. Arias-Camison; Joseph Lau; Cynthia H. Cole; Ivan D. Frantz III πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

We performed a systematic review of randomized controlled trials to determine whether the use of dexamethasone therapy in the first 15 days of life is beneficial for prevention of chronic lung disease in prematurely born infants. Studies were identified by conducting a literature search using the Me